O'Loughlin Steve 4
4 · Actinium Pharmaceuticals, Inc. · Filed Aug 14, 2020
Insider Transaction Report
Form 4
O'Loughlin Steve
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-08-12+59,066→ 59,066 totalExercise: $9.55Exp: 2030-08-12→ Common Stock (59,066 underlying)
Footnotes (2)
- [F1]This price represents the closing price of the Company's common stock on the date of the board of directors approval of the grant.
- [F2]Pursuant to the terms of the Company's Amended and Restated 2013 Stock Plan and 2019 Stock Plan, 2% of the options will vest each month from August 12, 2020 until fully vested.